Cargando…
Cyclophilin A/EMMPRIN Axis Is Involved in Pro-Fibrotic Processes Associated with Thoracic Aortic Aneurysm of Marfan Syndrome Patients
Background: Marfan syndrome (MFS) is a genetic disease, characterized by thoracic aortic aneurysm (TAA), which treatment is to date purely surgical. Understanding of novel molecular targets is mandatory to unveil effective pharmacological approaches. Cyclophilin A (CyPA) and its receptor EMMPRIN are...
Autores principales: | Perrucci, Gianluca L., Rurali, Erica, Corlianò, Maria, Balzo, Maria, Piccoli, Michela, Moschetta, Donato, Pini, Alessandro, Gaetano, Raffaella, Antona, Carlo, Egea, Gustavo, Fischer, Gunter, Malešević, Miroslav, Alamanni, Francesco, Cogliati, Elisa, Paolin, Adolfo, Pompilio, Giulio, Nigro, Patrizia |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7016677/ https://www.ncbi.nlm.nih.gov/pubmed/31936351 http://dx.doi.org/10.3390/cells9010154 |
Ejemplares similares
-
Soluble EMMPRIN levels discriminate aortic ectasia in Marfan syndrome patients
por: Rurali, Erica, et al.
Publicado: (2019) -
Cyclophilin A in Arrhythmogenic Cardiomyopathy Cardiac Remodeling
por: Rurali, Erica, et al.
Publicado: (2019) -
Integrin ανβ5 in vitro inhibition limits pro-fibrotic response in cardiac fibroblasts of spontaneously hypertensive rats
por: Perrucci, Gianluca Lorenzo, et al.
Publicado: (2018) -
Cyclophilin A: a key player for human disease
por: Nigro, P, et al.
Publicado: (2013) -
Marfan Syndrome: Enhanced Diagnostic Tools and Follow-up Management Strategies
por: Marelli, Susan, et al.
Publicado: (2023)